A study for a 75 year old man who takes Micardis, Bystolic (an AI-powered real world drug study)
Summary:
37 males aged 75 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 75 year old male patient who has Blood Pressure Fluctuation. The study is created by eHealthMe based on reports from sources including the FDA.
37 males aged 75 (±5) who take Micardis, Bystolic and have adverse effects are studied.
Number of reports submitted per year:

Information of the patient in this study:
- Age: 75
- Gender: male
- Conditions: Blood Pressure Fluctuation
- Drugs taken:
- Micardis (telmisartan)
- Bystolic (nebivolol hydrochloride)
Common drug interactions *:
- Overdose : 6 people, 16.22%
- Low Density Lipoprotein Increased (cholesterol increased in blood): 5 people, 13.51%
- High Blood Cholesterol : 5 people, 13.51%
- Diarrhea : 5 people, 13.51%
- Weakness : 4 people, 10.81%
- Malaise (a feeling of general discomfort or uneasiness): 4 people, 10.81%
- Fatigue (feeling of tiredness): 4 people, 10.81%
- Dyspnea Exertional : 4 people, 10.81%
- Dyspnea (difficult or laboured breathing): 4 people, 10.81%
- Gait Disturbance : 3 people, 8.11%
- Haemoglobin Decreased : 3 people, 8.11%
- Drug Ineffective : 3 people, 8.11%
- Constipation : 3 people, 8.11%
- Muscle Aches (muscle pain): 3 people, 8.11%
- Aplasia Pure Red Cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells): 3 people, 8.11%
- Acute Kidney Failure : 3 people, 8.11%
- Dizziness : 2 people, 5.41%
- Oedema Peripheral (superficial swelling): 2 people, 5.41%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 5.41%
- Therapeutic Response Decreased (less preventive response): 2 people, 5.41%
Common co-existing conditions *:
You may use this to check any potential undetected conditions.
- Pain : 8 people, 21.62%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 16.22%
- Muscle Spasms (muscle contraction): 6 people, 16.22%
- Dyslipidaemia (abnormal amount of lipids): 6 people, 16.22%
- Enlarged Prostate : 6 people, 16.22%
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 16.22%
- Chronic Renal Failure (kidney failure): 4 people, 10.81%
- Diabetes : 4 people, 10.81%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 8.11%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 8.11%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 8.11%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 8.11%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.41%
- Bone Pain : 2 people, 5.41%
- Type 2 Diabetes : 2 people, 5.41%
- Insulin-Requiring Type 2 Diabetes Mellitus : 2 people, 5.41%
- Multiple Myeloma (cancer of the plasma cells): 2 people, 5.41%
- Renal Cell Carcinoma (a kidney cancer): 2 people, 5.41%
- Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 2 people, 5.41%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 2.70%
Common co-used drugs *:
You may use this to check any potential interacting drugs.
- Furosemide (11 people, 29.73%)
- Digoxin (7 people, 18.92%)
- Allopurinol (7 people, 18.92%)
- Piroxicam (6 people, 16.22%)
- Enbrel (6 people, 16.22%)
- Neupogen (5 people, 13.51%)
- Pantoprazole Sodium (5 people, 13.51%)
- Naproxen (5 people, 13.51%)
- Myfortic (5 people, 13.51%)
- Pradaxa (5 people, 13.51%)
- Methocarbamol (5 people, 13.51%)
- Aranesp (5 people, 13.51%)
- Prograf (5 people, 13.51%)
- Metformin (5 people, 13.51%)
- Combivent (5 people, 13.51%)
- Eliquis (4 people, 10.81%)
- Coenzyme Q10 (4 people, 10.81%)
- Protonix (4 people, 10.81%)
- Sodium Bicarbonate (4 people, 10.81%)
- Prednisone (4 people, 10.81%)
Drug effectiveness *:
Micardis:
n/a
Bystolic:
n/a
* Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drug side effects in long term, by gender and age:
Treatments, associated medications and conditions:
- Blood pressure fluctuation: 40,536 reports
Drug interactions:
- Micardis and Bystolic drug interaction (162 reports)
How the phase IV clinical study uses the data?
The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.